The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
The Transformation Rate of Moles (Melanocytic Nevi) Into Cutaneous Melanoma: A Population-Based Estimate
Abstract
BACKGROUND: Moles, or melanocytic nevi, are both markers of an increased risk of cutaneous melanoma and direct precursor lesions. Recent strategies to reduce the burden of advanced disease have focused on early detection and ongoing surveillance of moles for malignant degeneration. Inherent in this approach is the notion that moles exhibit a certain risk of transformation into melanoma; however, this risk is unknown. OBJECTIVE: To estimate the risk of moles transforming into cutaneous melanoma. DESIGN: We first constructed a model of transformation based on the assumption that the minimal number of moles turning into cutaneous melanoma per year is roughly equivalent to the number of melanomas diagnosed each year with associated nevic components. The annual risk was then calculated as the number of mole-associated melanomas diagnosed in 1 year (stratified by 10-year age groups) divided by the number of moles in a the same 10-year age group. We also estimated the cumulative risk during the lifetime of an individual mole by using a modification of the standard life table method. RESULTS: The annual transformation rate of any single mole into melanoma ranges from 0.0005% or less (ie, </=1 in 200,000) for both men and women younger than 40 years to 0.003% (about 1 in 33,000) for men older than 60 years. The rate is similar between men and women younger than 40 years but becomes substantially higher for men older than 40 years. For a 20-year-old individual, the lifetime risk of any selected mole transforming into melanoma by age 80 years is approximately 0.03% (1 in 3,164) for men and 0.009% (1 in 10,800) for women. CONCLUSIONS: The risk of any particular mole becoming melanoma is low, especially in younger individuals. However, since moles can disappear, ones that persist into old age have an increased risk of malignant degeneration. For young people with innumerable moles and no other associated risk factors, systematic excision of benign-appearing lesions would be of limited benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.1.23 · Cited by 2,917
Number of melanocytic nevi as a major risk factor for malignant melanoma
Holly, E. A., Kelly, J. W., Shpall, S. N., & Chiu, S.-H. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70230-8 · Cited by 503
Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma
Tucker, M. A. (1997) · JAMA · doi:10.1001/jama.277.18.1439 · Cited by 371
PERSONAL RISK-FACTOR CHART FOR CUTANEOUS MELANOMA
Mackie, R., Freudenberger, T., & Aitchison, T. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92097-7 · Cited by 308
Garbe, C., Krüger, S., Orfanos, C. E., Büttner, P., Weiß, J., Soyer, H. P., Stocker, U., Roser, M., Weckbecker, J., Panizzon, R., et al. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12374280 · Cited by 288
MACKIE, R. M., ENGLISH, J., AITCHISON, T. C., FITZSIMONS, C. P., & WILSON, P. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb02060.x · Cited by 241
Benign melanocytic lesions: Risk markers or precursors of cutaneous melanoma?
Skender-Kalnenas, T. M., English, D. R., & Heenan, P. J. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90294-5 · Cited by 186
Nicholls, E. M. (1973) · Cancer · doi:10.1002/1097-0142(197307)32:1<191::aid-cncr2820320129>3.0.co;2-w · Cited by 157
Brochez, L., Verhaeghe, E., Grosshans, E., Haneke, E., Pierard, G., Ruiter, D. J., & Naeyaert, J. M. (2002) · The Journal of Pathology · doi:10.1002/path.1061 · Cited by 152
Wachsmuth, R. C., Gaut, R. M., Barrett, J. H., Saunders, C. L., Randerson‐Moor, J. A., Eldridge, A., Martin, N. G., Bishop, D. T., & Newton‐Bishop, J. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01415.x · Cited by 131
Anatomic Distribution of Acquired Melanocytic Nevi in White Children
Gallagher, R. P. (1990) · Archives of Dermatology · doi:10.1001/archderm.1990.01670280050008 · Cited by 125
Markers and Relative Risk in a German Population for Developing Malignant Melanoma
Garbe, C., Krüger, S., Stadler, R., Guggenmoos-Holzmann, I., & Orfanos, C. E. (1989) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1989.tb04604.x · Cited by 117
Augustsson, A., Stierner, U. K., Rosdahl, I. K., & Suurküla, M. B. (1991) · Acta Dermato Venereologica · doi:10.2340/0001555571518524 · Cited by 115
Melanocytic Tumors of the Skin
Stern, J. B., Elder, D. E., & Murphy, G. F. (1994) · American Journal of Dermatopathology · doi:10.1097/00000372-199408000-00017 · Cited by 114
Gruber, S. B., Barnhill, R. L., Stenn, K. S., et al. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70253-x · Cited by 112
Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi
CARR, J., & Mackie, R. M. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08460.x · Cited by 99
Body-Site Distribution of Melanocytic Nevi in Young Australian Children
Harrison, S. L., Buettner, P., & MacLennan, R. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.1.47 · Cited by 81
Prevalence of common and dysplastic naevi in a Swedish population
Augustsson, A., Stierner, U. K., Suurküla, M. B., & Rosdahl, I. K. (1991) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1991.tb00424.x · Cited by 75
Augustsson, A., Stierner, U. K., Rosdahl, I. K., & Suurküla, M. B. (1992) · Acta Dermato Venereologica · doi:10.2340/0001555572123127 · Cited by 70
Cited by
Management of Cutaneous Melanoma
Tsao, H., Atkins, M. B., & Sober, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041245 · Cited by 855
Self-citationSaginala, K., Barsouk, A., Aluru, J. S., Rawla, P., & Barsouk, A. (2021) · Medical Sciences · doi:10.3390/medsci9040063 · Cited by 514
Elder, D. E., Bastian, B. C., Cree, I. A., Massi, D., & Scolyer, R. A. (2020) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2019-0561-ra · Cited by 502
Ultraviolet radiation and the skin: Photobiology and sunscreen photoprotection
Young, A. R., Claveau, J., & Rossi, A. B. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.09.038 · Cited by 339
Whiteman, D. C., Pavan, W. J., & Bastian, B. C. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00880.x · Cited by 273
Metadata
- Authors
- Tsao, H.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2003-03-01
- Volume
- 139
- Issue
- 3
- Pages
- 282
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2063886094
- Cited by
- 333
- References
- 19
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.